Apr 21, 2021 8:00 am EDT Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
Mar 17, 2021 4:15 pm EDT ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
Mar 15, 2021 4:05 pm EDT Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
Mar 4, 2021 8:00 am EST Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
Mar 1, 2021 4:05 pm EST Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
Feb 3, 2021 8:29 am EST Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
Jan 20, 2021 8:13 am EST ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES
Jan 5, 2021 8:00 am EST ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT
Jan 4, 2021 7:00 am EST ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
